12/4
07:44 am
incy
Trevi Therapeutics appoints new CFO [Seeking Alpha]
Low
Report
Trevi Therapeutics appoints new CFO [Seeking Alpha]
12/3
04:30 pm
incy
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12/3
03:16 pm
incy
Incyte Corporation (INCY) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Incyte Corporation (INCY) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
12/2
09:15 am
incy
Incyte and Winnie Harlow Join Forces to Share Her Personal Vitiligo Story and Spark Conversation and Understanding
Low
Report
Incyte and Winnie Harlow Join Forces to Share Her Personal Vitiligo Story and Spark Conversation and Understanding
12/1
08:00 am
incy
Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel
Low
Report
Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel
11/27
07:07 pm
incy
Incyte (INCY) Up 17.2% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Low
Report
Incyte (INCY) Up 17.2% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
11/27
04:11 am
incy
Incyte: This Profitable Biotech Trades Like A Melting Iceberg [Seeking Alpha]
Low
Report
Incyte: This Profitable Biotech Trades Like A Melting Iceberg [Seeking Alpha]
11/27
01:12 am
incy
Incyte: Riding Jakafi, Bracing For Generic Headwinds [Seeking Alpha]
Low
Report
Incyte: Riding Jakafi, Bracing For Generic Headwinds [Seeking Alpha]
11/24
07:19 am
incy
Incyte (NASDAQ:INCY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Incyte (NASDAQ:INCY) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
11/19
08:00 am
incy
Incyte to Present at Upcoming Investor Conferences
Medium
Report
Incyte to Present at Upcoming Investor Conferences
11/17
01:13 am
incy
Incyte Announces Positive CHMP Opinion for Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL) [Yahoo! Finance]
Low
Report
Incyte Announces Positive CHMP Opinion for Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL) [Yahoo! Finance]
11/17
01:00 am
incy
Incyte Announces Positive CHMP Opinion for Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)
Low
Report
Incyte Announces Positive CHMP Opinion for Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL)
11/14
11:13 am
incy
Incyte Stock Outlook: Is Wall Street Bullish or Bearish? [Yahoo! Finance]
Low
Report
Incyte Stock Outlook: Is Wall Street Bullish or Bearish? [Yahoo! Finance]
11/14
12:00 am
incy
Why Analysts See Incyte's Story Shifting as Pipeline Progress Drives New Valuation Targets [Yahoo! Finance]
Low
Report
Why Analysts See Incyte's Story Shifting as Pipeline Progress Drives New Valuation Targets [Yahoo! Finance]
11/13
09:41 am
incy
Incyte (INCY): Exploring Valuation After Recent Share Price Rally and Pipeline Progress [Yahoo! Finance]
Low
Report
Incyte (INCY): Exploring Valuation After Recent Share Price Rally and Pipeline Progress [Yahoo! Finance]
11/12
06:43 am
incy
Incyte (NASDAQ:INCY) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Incyte (NASDAQ:INCY) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/11
05:01 am
incy
Incyte (NASDAQ:INCY) Q3 Earnings: Leading The Immuno-Oncology Pack [Yahoo! Finance]
Low
Report
Incyte (NASDAQ:INCY) Q3 Earnings: Leading The Immuno-Oncology Pack [Yahoo! Finance]
11/10
01:53 pm
incy
Incyte Corporation (INCY) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
Low
Report
Incyte Corporation (INCY) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
11/10
10:41 am
incy
PharmaEssentia USA Announces Appointment of Dr. Barry Flannelly as Independent Director [Yahoo! Finance]
Low
Report
PharmaEssentia USA Announces Appointment of Dr. Barry Flannelly as Independent Director [Yahoo! Finance]
11/6
10:39 am
incy
Is It Time to Reevaluate Incyte After Strong Pipeline Update and 52% Price Surge? [Yahoo! Finance]
Low
Report
Is It Time to Reevaluate Incyte After Strong Pipeline Update and 52% Price Surge? [Yahoo! Finance]
11/6
10:01 am
incy
Incyte's Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema [Yahoo! Finance]
Low
Report
Incyte's Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema [Yahoo! Finance]
11/6
09:15 am
incy
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema
Low
Report
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema
11/4
10:38 pm
incy
Natera (NTRA) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
Low
Report
Natera (NTRA) Reports Earnings Tomorrow: What To Expect [Yahoo! Finance]
11/4
11:54 am
incy
Incyte (NASDAQ:INCY) had its price target raised by analysts at Piper Sandler from $82.00 to $102.00. They now have an "overweight" rating on the stock.
Low
Report
Incyte (NASDAQ:INCY) had its price target raised by analysts at Piper Sandler from $82.00 to $102.00. They now have an "overweight" rating on the stock.
11/3
09:31 am
incy
Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting
Medium
Report
Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting